In a filing, Adicet Bio Inc revealed its 10% Owner ORBIMED ADVISORS LLC acquired Company’s shares for reported $5.0 million on Oct 08 ’25. In the deal valued at $1.00 per share,5,000,000 shares were bought. As a result of this transaction, ORBIMED ADVISORS LLC now holds 9,026,359 shares worth roughly $8.12 million.
A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who decreased its forecast for the stock in mid September from “a Buy” to “a Neutral”. JMP Securities also remained covering ACET and has decreased its forecast on June 27, 2023 with a “Mkt perform” recommendation from previously “Mkt outperform” rating. Guggenheim revised its rating on June 27, 2023. It rated ACET as “a Neutral” which previously was an “a Buy”.
Price Performance Review of ACET
On Monday, Adicet Bio Inc [NASDAQ:ACET] saw its stock jump 1.33% to $0.9. Over the last five days, the stock has lost -8.80%. Adicet Bio Inc shares have fallen nearly -37.38% since the year began. Nevertheless, the stocks have fallen -6.26% over the past one year. While a 52-week high of $1.48 was reached on 01/03/25, a 52-week low of $0.45 was recorded on 04/10/25.
Levels Of Support And Resistance For ACET Stock
The 24-hour chart illustrates a support level at 0.8512, which if violated will result in even more drops to 0.8006. On the upside, there is a resistance level at 0.9312. A further resistance level may holdings at 0.9606.
How much short interest is there in Adicet Bio Inc?
A steep rise in short interest was recorded in Adicet Bio Inc stocks on 2025-10-15, growing by 2.61 million shares to a total of 7.39 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-15 was 4.78 million shares. There was a rise of 35.29%, which implies that there is a positive sentiment for the stock.
